Clexio Biosciences

Clexio Biosciences is a CNS-first clinical-stage pharmaceutical company. Our therapies are designed to address patients unmet needs through scientifically based integration of drugs with innovative technologies. Clexios growing pipeline is focused on the development of safe and effective treatments with rapid onset of action for a wide range of neurological and psychiatric conditions, including Major Depressive Disorder, Parkinsons Disease, Pain and other conditions involving impairment of the neurological system. Patients, and what they are living with, are at the center of everything we do. Our passion is to find ways to help patients regain a sense of balance, health and...

Depression,cns,psychiatry,parkinson,drug development,and cluster headache

Clexio biosciences operates in the Pharmaceutical manufacturing industry.

Clexio biosciences's revenue is 11m - 100m

Clexio biosciences has 11 - 50 employees.